top of page


   Day 01   
   ( 29th July 2023 )  



  • Long-term Risk of Carotid Stenosis and Cerebrovascular Disease after Radiation Therapy for Head and Neck Cancer
  • Predictors of radiation necrosis and dose/volume tolerance of the brain after three-fraction radiosurgery for brain metastases: A large single-institutional analysis
  • A Phase II Study of Volume and Dose De-Intensification Following Transoral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma
  • ctHPVDNA and Recurrence Risk in MC1675, a secondary analysis of a Phase III Evaluation of De-escalated Adjuvant Radiation Therapy (DART) versus Standard Adjuvant Treatment for HPV Associated Oropharyngeal Squamous Cell Carcinoma
  • MGMT Promotor Methylation Predicts Survival in Low-Grade and Anaplastic Gliomas after Alkylating Chemotherapy
  • Comparative evaluation of the sum of longest diameter measurements as per rectist 1.1 vs cect based volumetric estimation for response assessment in locally advanced head and neck cancer



  • NRG RTOG 1005: A Phase III Trial of Hypo fractionated Whole Breast Irradiation with Concurrent Boost Versus Conventional Whole Breast Irradiation plus Sequential Boost following Lumpectomy for High Risk Early-Stage Breast Cancer (PLENARY SESSION)
  • Accelerated Partial Breast Irradiation (2021) Using Five Daily Fractions: A Prospective, Phase II, Multi-centre Trial of Cosmetic Outcomes and Toxicity: Final Results
  • Ultra-accelerated photons, protons, or brachytherapy for favorable early breast cancer: long-term results of a 3-fraction partial breast irradiation trial
  • Concurrent Olaparib with radiotherapy in patients with triple negative breast cancer: final results of the RADIOPARP phase 1 trial
  • Radiotherapy Use and Incidence of Locoregional Recurrence in Patients with Favorable-Risk Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial



  • Non-operative management is feasible and safe in patients with rectal cancer who achieve clinical complete response to short-course radiation therapy and consolidation chemotherapy
  • Radiotherapy Enhance the Immune Checkpoint Inhibitors Efficacy in advanced liver cancer
  • Multi-Institutional Comparison Of Ablative Radiation Therapy In 5 Versus 15-25 Fractions For Locally Advanced Pancreatic Cancer
  • Neoadjuvant Chemoradiotherapy Significantly Improved R0 Resection Rate in Unresectable Locally Advanced Colon Cancer: the Initial Analysis from the Randomized Controlled Phase 3 Trial.
  • Concurrent chemoradiation of different doses (50.4 Gy vs. 59.4 Gy) and different target field (ENI versus IFI) for locally advanced esophageal squamous cell carcinoma: results from a randomized, multicenter phase Ⅲ clinical trial



  • Conventional vs Hypofractionated, radiotherapy for high-risk prostate cancer: 7-year outcomes of the randomized, non-inferiority, phase 3 PCS5 trial
  • The Influence of Pelvic Lymph Node Dissection Volumes on Clinical Outcomes in NRG/RTOG 0534
  • Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle invasive bladder cancer (MIBC)
  • Long-term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney)
  • Bladder Only Versus Bladder Plus Pelvic Lymph Node Chemoradiation for Muscle-Invasive Bladder Cancer
  • Predictive Value of Ga68-PSMA PETCT-Based Response to Neoadjuvant Androgen Deprivation Therapy in Node Positive Prostate Cancer Treated with Radical Radiotherapy




  • Pembrolizumab plus Concurrent Chemoradiation Therapy (cCRT) for Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799 2-Year Update
  • Effect of EGFR-TKIs Combined with Cerebral Radiotherapy on Prognosis of Patients with EGFR-Mutant Lung Adenocarcinoma with Brain Metastasis
  • Relationship Between Cardiac Dose and Overall Survival after Radiotherapy in a Large Cohort of Patients with Locally Advanced NSCLC
  • Prospective Single-arm Trial of preoperative 42.75 Gy in 15 fractions for soft tissue sarcoma of the extremity/trunk
  • Role of Adjuvant Regional Nodal Irradiation in Resected Melanoma: A Secondary Analysis of SWOG S1404



  • Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiotherapy to Conventional Palliative External Beam Radiotherapy
  • Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy for Patients with Brain Metastases: A Multi-Institutional Analysis
  • Stereotactic Body Radiation Therapy for High-Grade Malignant Epidural Spinal Cord Compression from Solid Tumor Metastases
  • Stereotactic Body Radiation Therapy versus Conventional External Beam Radiation Therapy for Painful Bone Metastases: A Systematic Review and Meta-analysis of Randomized Trials
  • Liver function preservation and outcome after SBRT with functional treatment planning in patients with HCC and advanced hepatic cirrhosis: from nuclear medicine to MRI-based functional treatment planning platform.
  • Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Primary Endpoint Analysis Phase III Randomized Trial
  • Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent, or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study
  • iSABR: Safety and Efficacy Results from a Phase II Study of SABR in Combination with Durvalumab for Early-Stage Medically Inoperable NSCLC
  • Thirteen Years with Preoperative 5x5 Gy in Soft Tissue Sarcomas: A Pattern of Local Failure
  • Stereotactic Ablative Radiation Therapy for Sarcoma Lung Metastases: indications for treatment and patterns of failure



  • A Pilot Study of Moderately Hypo-Fractionated Whole Pelvic Radiotherapy with Concurrent Chemotherapy and Image Guided High Dose Rate Brachytherapy for Locally Advanced Cervical Carcinoma
  • The role of circulating tumor cells as potential predictive and prognostic factors in cervical cancers
  • Definitive High-Dose Radiotherapy for Primary Vulvar Cancer: The DRIVE Multicenter Cohort Study
  • Improved Outcomes with Adjuvant Radiation Therapy in Early-Stage Endometrial Cancer with Abnormal Beta-Catenin Expression
  • Impact of Adjuvant Pelvic External Beam Radiotherapy or Vaginal Brachytherapy on Clinical Outcomes for Early-Stage Uterine Carcinosarcoma


   Day 02   
   ( 30th July 2023  )  



  • Preclinical research platform for ocular FLASH radiotherapy by Devin Miles, Daniel Sforza, Marisol Cano, James T Handa, John W Wong, Mohammad Rezaee.
  • Correlation of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Feasibility of Coronary Artery Sparing Treatment Planning in Lung Cancer
  • Pulmonary Function Test Results of Patients Treated on a Two-Institution, 4DCT-Ventilation Functional Avoidance Prospective Clinical Trial
  • Daily Assessment of On-Treatment Tumor Regression by Cone Beam CT as a Prognostic Dynamic Biomarker in Nasopharyngeal Cancer
  • Prospective Clinical Integration of AI Based Treatment Planning tool for whole breast radiation therapy (WBRT): A single institution’s three-year experience
  • Examining the Impact of Direct Patient Care for Medical Physicists: A Randomized Prospective Phase III Trial
  • Deep Learning-Driven Real-Time Liver Tumor Localization Via Optical Surface Imaging and Biomechanical Modeling
  • Spatially Fractionated Radiation Therapy in the Modern Era: The Mayo Clinic Experience
  • SDDRO-DMF: Simultaneous Dose and Dose Rate Optimization with FLASH predictive modeling of Dose Modifying Factor



  • Impact of Myc-Altered Pathology on Radiotherapy Efficacy Among Patients with Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Retrospective Study
  • Outcomes and Failure Patterns for >500 Patients Treated for Primary CNS Lymphoma: Exploring Modern Roles for Radiotherapy
  • Radiation Therapy for Bridging and Improving CAR-T Cell Therapy
  • Outcomes of Salvage Radiotherapy in Refractory or Relapsed High-Grade B-Cell Lymphoma Patients Treated with Commercial CAR T-Cell Therapy
  • 18FDG PET/CT Parameters for the Prediction of CAR T-Cell Therapy Response among Patients with Large B-Cell Lymphoma
  • Local Failure in Non-metastatic Ewing Sarcoma Patients Treated with Definitive Radiation Therapy on AEWS1031: A Report from the Children’s Oncology Group
  • Volumetric Modulated Arc Therapy Total Body Irradiation (VMAT-TBI) in Pediatric and Adolescent/Young Adult Patients Undergoing Stem Cell Transplantation: Early Outcomes and Toxicities



  • Does compromising target coverage impact overall survival when treating Oligometastatic Disease with Stereotactic Ablative Radiotherapy (SABR)?
  • FAST-01: Results of the First-In-Human Study of Proton FLASH Radiotherapy
  • Hypofractionated Two Week Short-Course Radiotherapy vs. Monthly Single Fraction Palliative Pelvic Radiation in Advanced Gynaecologic Cancers
  • Patient Reported Outcomes after Frameless Virtual Cone radiosurgery for Trigeminal Neuralgia
  • Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial


bottom of page